Refractory polymyositis undergoing remission following antitubercular therapy

BMJ Case Rep. 2015 Apr 22:2015:bcr2015209291. doi: 10.1136/bcr-2015-209291.

Abstract

Opportunistic infections pose a significant problem in patients receiving immunosuppressive therapy for autoimmune diseases. We present a case of a woman with polymyositis refractory to high-dose steroid and methotrexate, as a consequence of which she developed miliary tuberculosis. Her myositis went into remission after initiation of antitubercular therapy, in spite of bringing down the intensity of immunosuppression. This is the first reported case of myositis undergoing remission after treating intercurrent infection, and illustrates the complex relationship between autoimmune disease and host response to infection.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / adverse effects*
  • Antitubercular Agents / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunocompromised Host
  • Immunosuppression Therapy / adverse effects*
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Middle Aged
  • Polymyositis / drug therapy*
  • Polymyositis / immunology
  • Remission Induction
  • Tuberculosis, Miliary / drug therapy*
  • Tuberculosis, Miliary / etiology*
  • Tuberculosis, Miliary / immunology

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Antitubercular Agents
  • Methotrexate